Treatment of Type2 Diabetes
-
Aging Doesn’t Have To Mean Giving In On Quality
It’s crucial to stay engaged with your health care professionals and talk
Read More » -
-
Good News About GLP-1 Drugs and Cardiovascular Health
A popular non-insulin injectable drug that long ago met the FDA cardiovascular safety test can now claim a cardiovascular benefit.
Read More » -
Weighing the Benefits of a Bariatric Procedure
When diet and lifestyle changes to combat obesity don’t work, surgical approaches and new generation devices can, but they all…
Read More » -
Janssen’s SGLT-2 Drugs and Risk of Amputations: What Happened, and What’s Next?
The European regulators have applied their amputation risk warning to all Janssen products in the SGLT-2 inhibitor class. But FDA…
Read More » -
Keeping Diabetic Eye Disease In Check
Here’s our reminder that you need to visit your eye doctor regularly to check for signs of diabetic retinopathy. We’re…
Read More » -
Having A Look At The American Diabetes Association’s 2017 Clinical Practice Update
Many T2D’s treat almost exclusively with the family doctor. The American Diabetes Association publishes an annual update of its clinical…
Read More » -
FDA To Require Prominent Amputation Risk Warning for Canagliflozin SGLT-2 Inhibitors
Post-market clinical trials of the Type 2 medication canagliflozin to assess cardiovascular and renal risks have affirmed a suspected link…
Read More » -
A Lesson From The World’s Second Oldest Mode of Human Self-Propulsion
A 105-year-old cyclist upends the idea that exercise gets us only so far.
Read More » -
A Common Sense Approach to Nutrition
A lesson from the environmental movement – reduce and recycle. Here’s the “reduce” side of the equation.
Read More »